![Azithromycin Dihydrate](/ProductImageEN/2023-05/Large/d1281dc6-a05d-447e-9a13-628a52607cbd.png)
Azithromycin Dihydrate NEW
Price | Get Latest Price | ||
Package | 1Kg/Bag | 25Kg/Bag | 100Kg/Bag |
Min. Order: | 1Kg/Bag |
Supply Ability: | 20 tons |
Update Time: | 2024-09-10 |
Product Details
Product Name: Azithromycin Dihydrate | CAS No.: 117772-70-0 |
EC-No.: 641-134-5 | Min. Order: 1Kg/Bag |
Purity: 99% up, High Density | Supply Ability: 20 tons |
Release date: 2024/09/10 |
Product Information
Product name | Imatinib Mesylate |
Molecular Formula | C30H35N7O4S |
Molecular Weight | 589.71 |
CAS No. | 220127-57-1 |
Quality Standard | In-house standard |
Appearance | White powder |
COA of Imatinib Mesylate
TEST ITEMS | SPECIFICATION | RESULTS |
Appearance | White or slightly yellow crystalline powder, | Slightly yellow crystalline Powder |
Solubility | Soluble in water and in acids solutions, slightly soluble | Confirm |
Identification | Complies | Confirm |
Water | ≤1.0% | 0.8% |
Heavy metals | ≤20ppm | 10ppm |
Melting range | 212 – 220℃ | 214-216℃ |
Residue on ignition | ≤0.1% | 0.08% |
Particle size | 90% < 100 μm 50% < 50 μm | Confirm |
Bulk density | NLT 0.4g/ml | 0.6g/ml |
Chromatographic purity | Individual impurities: ≤0.2% Total impurities: ≤0.5% | 0.16% 0.32% |
Assay | 98.5%-102.0% of Imatinib mesylate, calculated on anhydrous basis. | 99.70% |
Residual solvents | Ethyl acetate: ≤5000ppm | Confirm |
Acetone: ≤5000ppm | Confirm | |
N,N-Dimethylformamide: ≤880ppm | Confirm | |
Methanol: ≤3000ppm | Confirm | |
Dichloromethane: ≤300ppm | Confirm |
We provide you with high-quality imatinib mesylate powder and imatinib mesylate price is very reasonable and competitive.
Usage
Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl,
the causal agent in chronic myelogenous leukemia.
As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of
dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.
1. A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL)
2. Echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis
3. Anticancer
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$85.00/100KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-07 | |
$0.00/25kg |
VIP1Y
|
Henan Suikang Pharmaceutical Co.,Ltd.
|
2024-05-08 | |
$0.00/1kg |
VIP1Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-29 | |
$0.00/1kg |
VIP2Y
|
Hebei Kingfiner Technology Development Co.Ltd
|
2023-11-16 | |
$0.00/25KG |
VIP5Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2023-09-01 | |
$100.00/1kg |
Henan Bao Enluo International TradeCo.,LTD
|
2023-07-28 | ||
$232.00/10kg |
VIP3Y
|
Hebei Dangtong Import and export Co LTD
|
2023-03-17 | |
$90.00/25kg |
Beijing Mesochem Technology Co.,Ltd
|
2022-12-21 | ||
$90.00/1kg |
Hebei baicao biology science and technology co., ltd
|
2022-04-26 | ||
$25.00/1ASSAYS |
VIP6Y
|
Hebei Guanlang Biotechnology Co., Ltd.
|
2021-07-06 |
- Since: 1996-07-16
- Address: Fujian China ,16F, Huicheng Comm. Complex, 839 Xiahe RD.